Table 1.
Percent distribution of control and SG2NA knockdown cells in different phases of cell cycles after treating with thapsigargin (1 μM) and tunicamycin (1 μg/ml) at different time points
| Sub-G1 phase | G1/S phase | S phase | G2/M phase | |
|---|---|---|---|---|
| NIH3T3 (control) | 1.21 | 60.76 | 19.33 | 16.99 |
| NIH3T3 (Control) (TG 6 h) | 3.91 | 62.82 | 17.13 | 14.12 |
| NIH3T3 (control) (TG 24 h) | 3.20 | 68.48 | 11.09 | 17.62 |
| SG2NA kD | 1.71 | 70.69 | 13.48 | 12.99 |
| SG2NA kD (TG 6 h) | 5.35 | 64.78 | 14.84 | 11.57 |
| SG2NA kD (TG 24 h) | 9.38 | 64.46 | 10.76 | 14.88 |
| NIH3T3 (control) | 1.21 | 60.76 | 19.33 | 16.99 |
| NIH3T3 (control) (TM 6 h) | 1.61 | 60.57 | 19.81 | 15.24 |
| NIH3T3 (control) (TM 24 h) | 3.30 | 71.90 | 9.44 | 13.82 |
| SG2NA kD | 1.71 | 70.69 | 13.48 | 12.99 |
| SG2NA kD (TM 6 h) | 2.73 | 66.14 | 16.84 | 11.81 |
| SG2NA kD (TM 24 h) | 4.43 | 54.18 | 19.38 | 19.19 |